AI-QCT-derived total plaque volume conferred a higher relative risk of MACE in women (17.7% increase per 50-mm3; 95% CI 1.12-1.24) compared to men (5.3% increase; P_interaction<0.001).
Observational (n=3,551)
Yes
Does the prognostic value of AI-QCT coronary plaque features for MACE differ between women and men with suspected coronary artery disease?
AI-QCT derived coronary plaque features confer a significantly higher relative risk of MACE in women compared to men, despite men having a higher absolute plaque burden.
Relative Risk: 1.177 (95% CI 1.12–1.24)
Absolute Event Rate: 3.2% vs 6.1%
p-value: p=<0.001
Background: Coronary plaque features are imaging biomarkers of cardiovascular risk, but less is known about sex-specific patterns in their prognostic value. This study aimed to define sex differences in the coronary atherosclerotic phenotypes assessed by artificial intelligence-based quantitative computed tomography (AI-QCT) and the associated risk of major adverse cardiovascular events (MACEs). Methods: Global multicenter registry including symptomatic patients with suspicion of coronary artery disease referred for coronary computed tomography angiography. AI-QCT analyzed 16 coronary artery disease features. The primary end point was MACE defined as death, myocardial infarction, late revascularization, cerebrovascular events, unstable angina, and congestive heart failure. Results: Among 3551 patients (mean age, 59±12 years; 49. 5% women), MACE occurred in 3. 2% of women and 6. 1% of men during an average follow-up of 4. 8±2. 2 years. The AI-QCT features total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume were significantly higher in men (P<0. 001), and high-risk plaques were more prevalent (9. 2% versus 2. 5%; P<0. 0001). Independent of age and cardiovascular risk factors, the AI-QCT-derived features of total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume conferred a higher relative risk of MACE in women than men. For every 50-mm3 increase in total plaque volume, relative risk increased by 17. 7% (95% CI, 1. 12-1. 24) in women versus 5. 3% (95% CI, 1. 03-1. 07) in men (P₈₍ₓ₄ₑ₀₂ₓ₈₎₍<0. 001) ; for noncalcified plaque, relative risk increased by 27. 1% (95% CI, 1. 17-1. 38) versus 11. 6% (95% CI, 1. 08-1. 15; P₈₍ₓ₄ₑ₀₂ₓ₈₎₍=0. 0015) ; and for calcified plaque, relative risk increased by 22. 9% (95% CI, 1. 14-1. 33) versus 5. 4% (95% CI, 1. 01-1. 10; P₈₍ₓ₄ₑ₀₂ₓ₈₎₍=0. 0012), respectively. Similarly, for percentage atheroma volume, the risk was higher in women. The findings remained unchanged when restricted to a secondary composite end point (death and myocardial infarction). Conclusions: The AI-QCT plaque features, total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume, conferred a higher relative MACE risk in women and may prompt more aggressive antiatherosclerotic therapy and reinforced preventive interventions. Registration: URL: https: //www. clinicaltrials. gov; Unique identifier: NCT04279496.
Feuchtner et al. (Sun,) conducted a observational in Suspected coronary artery disease (n=3,551). AI-QCT coronary plaque features (e.g., total plaque volume) vs. Men was evaluated on MACE defined as death, myocardial infarction, late revascularization, cerebrovascular events, unstable angina, and congestive heart failure (RR 1.177, 95% CI 1.12-1.24, p=<0.001). AI-QCT-derived total plaque volume conferred a higher relative risk of MACE in women (17.7% increase per 50-mm3; 95% CI 1.12-1.24) compared to men (5.3% increase; P_interaction<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: